CVE-2026-133694: continuedev continue 2.0.0/2.1.0 · Command Injection
Source GCVE Database
Not known to be exploited · CVSS 5.3 Medium.
Data as of 20 Nov 2026, 22:32 UTC
Thin evidence
One scorer or none| CNA (VulDB) | CVSS 4.0 | 5.3 |
|---|---|---|
| CNA (VulDB) | CVSS 3.1 | 6.3 |
| CNA (VulDB) | CVSS 3.0 | 6.3 |
| CNA (VulDB) | CVSS 2.0 | 7.5 |
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:XExploitation evidence
Disclosed: evidence found.
CVE published 20 Nov 2026
Detectable: no evidence on record.
No public nuclei template indexed
Weaponized: no evidence on record.
No public exploit code indexed in Metasploit or Exploit-DB
Exploited in the wildExploited: no evidence on record.
Not in CISA KEV and no source reports exploitation
Observed by OffSeq MirageSeen by Mirage: no evidence on record.
No attack traffic recorded by OffSeq Mirage sensors
A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 20 Nov 2026.
What to do
Affected software
| Product | Affected | Fixed in |
|---|---|---|
| continuedevcontinue | Affected
| Fixed in– |
npmcontinuedev/continuepkg:npm/continuedev/continueOther threats | Affected
| Fixed in– |
Check your own hosts for these packages with threat-finder (opens in a new tab), our free open-source scanner.
AI-suggested
Users should exercise caution when using affected versions 2.0.0 and 2.1.0, especially regarding untrusted inputs that may reach the getSidebarContent function. Monitor vendor channels for any future advisories or patches.
Description
A security vulnerability (CVE-2026-133694) exists in continuedev continue versions 2.0.0 and 2.1.0. The flaw is in the getSidebarContent function within the Mermaid Diagram Renderer component, specifically in the file extensions/vscode/src/ContinueGUIWebviewViewProvider.ts. This vulnerability allows remote attackers to perform OS command injection. The vendor was contacted but has not responded or provided a fix. The CVSS score is 6.3, indicating a medium severity risk.